/ Life Sciences / Overview
Bioavailability reimagined.
Vegalab Life Sciences applies our patent-pending nano-encapsulation platform to the compounds that matter most for human health — and that the body has historically struggled to absorb.
A New Approach to Hard-to-Absorb Compounds
Many of the most promising molecules in modern health science — NAD+ precursors, resveratrol, CoQ10, glutathione, exosomes — are notoriously difficult to deliver effectively. Conventional supplements and topicals lose most of the active ingredient before it ever reaches the cells that need it. Vegalab's layer-by-layer nano-encapsulation technology changes that, protecting active compounds through digestion or transdermal application and releasing them precisely where the body can use them.
Therapeutic Ampoules
Vegalab manufactures a growing range of professional-use therapeutic ampoules for medical and clinical applications, including formulations with NAD+, exosomes, glutathione, hyaluronic acid, Vitamin C, topical anesthetics, antifungals, and other actives. These are developed under GMP manufacturing standards at our FDA- and EPA-registered facilities, with formulations supported by clinical evidence.
Advanced Nutraceuticals
Our supplement pipeline focuses on bioavailability-limited compounds where nano-encapsulation delivers the greatest measurable benefit. Current development priorities include NMN, resveratrol, CoQ10, mitochondrial support formulations, high-dose Vitamin C, and additional targets in cellular health and longevity science.
Built on Proven Science
Vegalab Life Sciences draws on more than a decade of formulation expertise developed across our agricultural, biosecurity, and beauty science divisions. The same nano-encapsulation, micronization, and logic-gated release technologies that have made Vegalab a recognized leader in biological agriculture now power our next generation of health products.
Logic-Gated Delivery
Our proprietary capsule architecture is programmable — engineered to release active compounds only when specific biological conditions are present. pH, enzymes, moisture, temperature, oxidative stress, and other physiological triggers can be combined as release conditions, dramatically reducing off-target activity and improving the consistency of biological response.
Manufacturing and R&D
Vegalab Life Sciences products are developed and manufactured at our Switzerland-headquartered facilities under strict GMP standards. Our integrated R&D and manufacturing infrastructure enables rapid formulation, scale-up, and product launch — the same advantage that has allowed Vegalab to bring more than 30 registered products to market across other divisions.
Partnerships and Distribution
Vegalab Life Sciences is currently expanding its distribution and partnership network for therapeutic ampoules and forthcoming supplement products. For licensing, white-label manufacturing, clinical distribution, or investment inquiries, please contact us.